Ondansetron ODT 8 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB25FSCYU
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,338
Award facts
- Contract value 100% obligated
- $1,338.34 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Ondansetron ODT 8 mg tablets in a quantity of 30, with a contract ceiling value of $1,338.34. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively awarded through open competition. The delivery location is the contractor's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of August 18, 2025. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a substantial value of $999,999,999.00 and extends through December 2026.
As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen supplies a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare systems. The parent IDC serves as a global pharmaceutical support vehicle enabling the company to deliver specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains to customers including the Defense Health Agency and U.S. Coast Guard. This specific delivery order for Ondansetron, an anti-nausea medication commonly used in clinical settings, represents one of numerous routine pharmaceutical deliveries the company fulfills under this expansive contract vehicle.
Quick answers
Who was awarded contract SPE2DB25FSCYU?
SPE2DB25FSCYU was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 15, 2025.
How much is contract SPE2DB25FSCYU worth?
The government has obligated $1,338 on SPE2DB25FSCYU.
Is contract SPE2DB25FSCYU an order under another contract?
Yes. SPE2DB25FSCYU is a delivery order under SPE2DB22D2211, an indefinite delivery contract.
Was contract SPE2DB25FSCYU competed?
The extent of competition for SPE2DB25FSCYU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award